Mind Med is the first psychedelic company to IPO. Backed by big names from big brands, Shark Tank and Tom's Shoes and Canopy Growth. MMED has in its portfolio (1) psychedelic-derived drug for the treatment of opiate addiction made from indigenous African plant iboga used in religious rituals for thousands of years (2) LSD microdosing trials.
+ 10x potential.
- Most private sale investors have no lockup. Last week the company did a pre-IPO round at $0.33 for about 24M
Not a lot to go on, but I'll buy it for the price. They have a drug that could eliminate opioid addiction, it's in a trial in Germany, which could be very interesting. I'm sure it's going to be a few years before the results hit the public. Possibly a take over stock soon.